We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPBD icon
701
Upbound Group
UPBD
$1.16B
$246K 0.02%
9,814
-8,835
-47% -$206K
DD icon
702
DuPont de Nemours
DD
$19.2B
$246K 0.02%
+2,861
New +$238K
PRI icon
703
Primerica
PRI
$9.89B
$246K 0.02%
899
-89
-9% -$23.6K
NVDA icon
704
PUT
NVIDIA
NVDA
$5.42T
$246K 0.02%
907
-80,593
-99% -$10.1M
NE icon
705
Noble Corp
NE
$6.51B
$246K 0.02%
9,262
-10,079
-52% -$242K
GOLD
706
Gold.com Inc
GOLD
$1.26B
$246K 0.02%
+11,069
New +$246K
ORI icon
707
Old Republic International
ORI
$10.4B
$245K 0.02%
+6,384
New +$240K
CW icon
708
Curtiss-Wright
CW
$25.5B
$245K 0.02%
501
-770
-61% -$304K
PD icon
709
PagerDuty
PD
$902M
$244K 0.02%
15,965
-60
-0.4% -$932
AMBA icon
710
Ambarella
AMBA
$3.81B
$244K 0.02%
3,692
-584
-14% -$31K
RACE icon
711
Ferrari
RACE
$72.5B
$243K 0.02%
+496
New +$230K
VRDN icon
712
Viridian Therapeutics
VRDN
$2.67B
$243K 0.02%
17,401
-50,268
-74% -$682K
EXEL icon
713
Exelixis
EXEL
$13.4B
$243K 0.02%
5,517
-919
-14% -$36.7K
NAMS icon
714
NewAmsterdam Pharma
NAMS
$3.34B
$243K 0.02%
+13,420
New +$245K
BDX icon
715
Becton Dickinson
BDX
$48.2B
$243K 0.02%
+1,409
New +$258K
JAKK icon
716
Jakks Pacific
JAKK
$293M
$242K 0.02%
11,662
+2,123
+22% +$43.2K
ZROZ icon
717
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.32B
$242K 0.02%
+3,610
New +$239K
CRI icon
718
Carter's
CRI
$1.47B
$241K 0.02%
8,000
EVR icon
719
Evercore
EVR
$11.8B
$241K 0.02%
+892
New +$196K
HHH icon
720
Howard Hughes
HHH
$4.03B
$241K 0.02%
3,563
-8,207
-70% -$561K
KC
721
Kingsoft Cloud Holdings
KC
$3.69B
$240K 0.02%
19,178
+1,172
+7% +$15.2K
MEDP icon
722
Medpace
MEDP
$16.5B
$240K 0.02%
765
+108
+16% +$32.4K
MUNI icon
723
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.12B
$239K 0.02%
+4,650
New +$237K
IBEX icon
724
IBEX
IBEX
$499M
$239K 0.02%
8,200
-2,500
-23% -$66.9K
ZION icon
725
Zions Bancorporation
ZION
$10.3B
$238K 0.02%
+4,577
New +$215K

Similar funds

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.